Levetiracetam monotherapy in patients with brain tumor-related epilepsy: Seizure control, safety, and quality of life

Journal of Neuro-Oncology

Volumn 104, Issue 1, 2011, Pages 205-214

  Maschio, Marta ^a   Dinapoli, Loredana ^a   Sperati, Francesca ^a   Pace, Andrea ^a   Fabi, Alessandra ^a   Vidiri, Antonello ^a   Muti, Paola ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Brain tumor related epilepsy; Chemotherapy; Efficacy; Levetiracetam; QoL; Radiotherapy

Indexed keywords

ETIRACETAM; FOTEMUSTINE; LOMUSTINE; OXCARBAZEPINE; PHENOBARBITAL; PROCARBAZINE; TEMOZOLOMIDE; TOPIRAMATE; VALPROIC ACID; VINCRISTINE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN LYMPHOMA; BRAIN TUMOR RELATED EPILEPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COGNITION; DISEASE CONTROL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MALE; MENINGIOMA; MONOTHERAPY; MORBIDITY; NEUROPSYCHOLOGICAL TEST; OLIGODENDROGLIOMA; QUALITY OF LIFE; RESTLESSNESS; SOCIAL STATUS; SOMNOLENCE;

ADULT; AGED; ANTICONVULSANTS; BRAIN NEOPLASMS; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PIRACETAM; QUALITY OF LIFE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052712680     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0460-x     Document Type: Article

References (52)

1. J Hildebrand C Lecaille J Perennes JY Delattre 2005 Epileptic seizures during follow-up of patients treated for primary brain tumors Neurology 65 212 215 16043788 10.1212/01.wnl.0000168903.09277.8f (Pubitemid 41022363)
2. M Maschio L Dinapoli A Vidiri, et al. 2009 The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine J Exp Clin Cancer Res 28 60 19419544 10.1186/1756-9966-28-60
3. M Maschio L Dinapoli F Saveriano, et al. 2009 Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report Acta Neurol Scand 120 210 212 19719809 10.1111/j.1600-0404.2009.01226.x 1:CAS:528:DC%2BD1MXhtFOkur7M
4. J Novy R Stupp AO Rossetti 2009 Pregabalin in patients with primary brain tumors and seizures: a preliminary observation Clin Neurol Neurosurg 111 171 173 18977587 10.1016/j.clineuro.2008.09.009
5. M Maschio L Dinapoli A Zarabla, et al. 2008 Outcome and tolerability of topiramate in brain tumor associated epilepsy J Neuro-Oncol 86 61 70 10.1007/s11060-007-9430-3 1:STN:280:DC%2BD2sjhsFSmug%3D%3D (Pubitemid 350263434)
6. M Maschio F Albani A Baruzzi, et al. 2006 Levetiracetam therapy in patients with brain tumour and epilepsy J Neuro-Oncol 80 97 100 10.1007/s11060-006-9162-9 1:CAS:528:DC%2BD28Xht12qtLvP (Pubitemid 44473268)
7. RB Khan DL Hunt SJ Thompson 2004 Gabapentin to control seizures in children undergoing cancer treatment J Child Neurol 19 97 101 15072101 (Pubitemid 38425760)
8. S Striano P Striano P Boccella C Noverino L Bilo 2002 Tiagabine in glial tumors Epilepsy Res 49 81 85 11948010 10.1016/S0920-1211(02)00005-0 1:CAS:528:DC%2BD38Xis1ensbc%3D (Pubitemid 34304209)
9. Dinapoli L, Maschio M, Jandolo B, et al. (2009) Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study. Neurol Sci May 5 [Epub ahead of print]
10. HB Newton SA Goldlust D Pearl 2006 Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients J Neuro-Oncol 78 99 102 10.1007/s11060-005-9070-4 1:CAS:528:DC%2BD28XotFeit7k%3D (Pubitemid 43786667)
11. E Perucca 2005 Clinically relevant drug interactions with antiepileptic drugs Br J Clin Pharmacol 61 246 255 10.1111/j.1365-2125.2005.02529.x
12. B Vincenzi D Snatini C Grilli A La Cesa C Dianzani G Tonini 2004 Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient J Clin Oncol 5 4649 4651 10.1200/JCO.2004.05.003 (Pubitemid 41185136)
13. D Aguiar R Pazo I Duran, et al. 2004 Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider J Neuro-Oncol 66 345 350 10.1023/B:NEON.0000014538.31561.bc (Pubitemid 38258350)
14. FG El Kamar JB Posner 2004 Brain metastases Semin Neurol 24 347 362 15637647 10.1055/s-2004-861530 (Pubitemid 40076112)
15. PY Wen PW Marks 2002 Medical management of patients with brain tumors Curr Opin Oncol 14 299 307 11981275 10.1097/00001622-200205000-00008 (Pubitemid 34492862)
16. Y Eralp A Aydiner F Tas P Saip E Topuz 2001 Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiation Am J Clin Oncol 24 347 350 11474258 10.1097/00000421-200108000-00005 1:STN:280: DC%2BD3MvmtVKjsg%3D%3D (Pubitemid 32730725)
17. MJ Glantz BF Cole PA Forsyth, et al. 2000 Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors Neurology 54 1886 1893 10822423 1:STN:280:DC%2BD3c3osVWhsA%3D%3D
18. G Micali K Linthicum N Han D West 1999 Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies Pharmacotherapy 19 223 227 10030773 10.1592/phco.19.3.223.30917 1:CAS:528:DyaK1MXhtleisbc%3D (Pubitemid 29072034)
19. HJ Mamon P Wen AC Burns YS Loeffler 1999 Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy Epilepsia 40 341 344 10080516 10.1111/j.1528-1157.1999.tb00715.x 1:STN:280:DyaK1M7nvVKjsw%3D%3D (Pubitemid 29164800)
20. S Oberndorfer M Piribauer C Marosi H Lahrmann P Hitzenberger W Grisold 2005 P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy J Neuro-Oncol 72 255 260 10.1007/s11060-004-2338-2 1:CAS:528:DC%2BD28Xltg%3D%3D (Pubitemid 40867409)
21. CJ Vecht M Van Breemen 2006 Optimizing therapy of seizures in patients with brain tumours Neurology 67 S4 S10 S13 17190914
22. R Soffietti P Cornu JY Delattre, et al. 2006 EFNS guidelines on diagnosis and treatment of brain metastases: report of an EFNS task force Eur J Neurol 13 674 681 16834697 10.1111/j.1468-1331.2006.01506.x 1:STN:280: DC%2BD28vhsVOgtA%3D%3D (Pubitemid 44139367)
23. GD Anderson 2004 Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs Neurology 63 Suppl 4 S3 S8 15557548 1:CAS:528:DC%2BD2cXhtFaht7vJ
24. J Hildebrand 2004 Management of epileptic seizures Curr Opin Oncol 16 314 317 15187884 10.1097/01.cco.0000127720.17558.38 (Pubitemid 38870035)
25. M Klein NH Engelberts HM van der Ploeg, et al. 2003 Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life Ann Neurol 54 514 520 14520665 10.1002/ana.10712 (Pubitemid 37176548)
26. PN Patsalos E Perucca 2003 Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs Lancet Neurol 2 473 481 12878435 10.1016/S1474-4422(03)00483-6 1:CAS:528:DC%2BD3sXmslamtbs%3D (Pubitemid 36876104)
27. CJ Vecht GL Wagner EB Wilms 2003 Interactions between antiepileptic and chemotherapeutic drugs Lancet Neurol 2 404 409 12849118 10.1016/S1474-4422(03) 00435-6 1:CAS:528:DC%2BD3sXms1yhsLk%3D (Pubitemid 36793932)
28. SM Chang JG Kuhn HI Robins 2001 A phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants Cancer 91 417 422 11180089 10.1002/1097-0142(20010115)91:2<417::AID-CNCR1016>3.0.CO;2-9 1:CAS:528:DC%2BD3MXhtVekur4%3D (Pubitemid 32099244)
29. PN Patsalos W Fröscher F Pisani CM van Rijn 2002 The importance of drug interactions in epilepsy therapy Epilepsia 43 365 385 11952767 10.1046/j.1528-1157.2002.13001.x 1:CAS:528:DC%2BD38XjtlSlur8%3D (Pubitemid 34297175)
30. JA French BE Gidal 2000 Antiepileptic drugs interactions Epilepsia 41 Suppl 8 S30 S36 11092610 10.1111/j.1528-1157.2000.tb02944.x 1:CAS:528: DC%2BD3cXosFSitb4%3D
31. MV Relling CH Pui JT Sandlund, et al. 2000 Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia Lancet 356 285 290 11071183 10.1016/S0140-6736(00)02503-4 1:CAS:528: DC%2BD3cXlsVOqsro%3D (Pubitemid 30459586)
32. K Villikka KT Kivisto H Maenpaa H Joensuu PJ Neuvonen 1999 Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors Clin Pharmacol Ther 66 589 593 10613614 1:CAS:528: DC%2BD3cXlsVanuw%3D%3D (Pubitemid 30014085)
33. DF Lehmann TE Hurteau N Newman TE Coyle 1997 Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors Clin Pharmacol Ther 62 225 229 9284859 10.1016/S0009-9236(97)90071-0 1:CAS:528:DyaK2sXmtVGisrk%3D (Pubitemid 27373471)
34. KY Yap WK Chui A Chan 2008 Drug interactions between chemotherapeutic regimens and antiepileptics Clin Ther 30 1385 1407 18803983 10.1016/j.clinthera. 2008.08.011 1:CAS:528:DC%2BD1cXhtF2rtLfI
35. CJ Vecht GL Wagner EB Wilms 2003 Interactions between antiepileptic and chemotherapeutic drugs Lancet Neurol 2 404 409 12849118 10.1016/S1474-4422(03) 00435-6 1:CAS:528:DC%2BD3sXms1yhsLk%3D (Pubitemid 36793932)
36. MS van Breemen EB Wilms CJ Vecht 2007 Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management Lancet Neurol 6 421 430 17434097 10.1016/S1474-4422(07)70103-5 (Pubitemid 46551867)
37. G Singh JH Rees JW Sander 2007 Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment J Neurol Neurosurg Psychiatry 78 342 349 17369589 10.1136/jnnp.2006.106211 (Pubitemid 46580538)
38. A Pace A Vidiri E Galiè, et al. 2003 Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response Ann Oncol 14 1722 1726 14630675 10.1093/annonc/mdg502 1:STN:280: DC%2BD3srltVWgsw%3D%3D (Pubitemid 38029042)
39. L Ngo M Nei J Glass 2006 Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma Epilepsia 47 1237 1238 16886989 10.1111/j.1528-1167.2006.00597.x (Pubitemid 44086761)
40. I Bosma MJ Vos JJ Heimans, et al. 2007 The course of neurocognitive functioning in high-grade glioma patients Neuro Oncol 9 53 62 17018697 10.1215/15228517-2006-012 (Pubitemid 46543489)
41. MA Weitzner CA Meyers 1997 Cognitive functioning and quality of life in malignant glioma patients: a review of the literature Psycho-oncol 6 169 177 10.1002/(SICI)1099-1611(199709)6:3<169::AID-PON269>3.3.CO;2-R 1:STN:280:DyaK2svlvVClsA%3D%3D (Pubitemid 27400533)
42. Pignatti F, van den Bent M, Curran D et al (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076-2084 (Pubitemid 34408798)
43. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events v4.0, http://ctep.cancer.gov/protocolDevelopment/electronic- applications/docs/ctcaev4.pdf
44. DR Macdonald TL Cascino SC Schold Jr JG Cairncross 1990 Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1277 1280 2358840 1:STN:280:DyaK3c3ptlyitQ%3D%3D (Pubitemid 20195640)
45. G Apolone A Filiberti S Cifani R Ruggiata P Mosconi 1998 Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients Ann Oncol 9 549 557 9653497 10.1023/A:1008264412398 1:STN:280:DyaK1czhslekuw%3D%3D (Pubitemid 28270644)
46. JA Cramer G Van Hammèe N132 Study Group 2003 Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam Epilepsy Behav 4 118 123 12697135 10.1016/S1525-5050(03)00004-0 (Pubitemid 37184582)
47. FG Gilliam AJ Fessler G Baker V Vahle J Carter H Attarian 2004 Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial Neurology 62 23 27 14718691 1:STN:280:DC%2BD2c%2FitFGhuw%3D%3D (Pubitemid 38082864)
48. PD Brown JC Buckner JR O'Fallon, et al. 2003 Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination J Clin Oncol 21 2519 2524 12829670 10.1200/JCO.2003.04.172 (Pubitemid 46606333)
49. DA Karnofsky JH Burchenal GC Armistead CM Southam JL Bernstein LF Craver CP Rhoads 1951 Triethylene melamine in the treatment of neoplastic disease Arch Int Med 87 477 516 1:STN:280:DyaG3M%2FjvFyiug%3D%3D
50. FI Mahoney DW Barthel 1965 Functional evaluation: The Barthel Index Md State Med J 14 61 65 14258950 1:STN:280:DyaF2M%2FmtlCltA%3D%3D
51. CA Meyers KR Hess 2003 Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression Neuro-Oncol 5 89 95 12672280 (Pubitemid 36416837)
52. A Rosati A Tomassini B Pollo C Ambrosi A Schwarz A Padovani B Sonetti 2009 Epilepsy in cerebral glioma: timing of appearance and histological correlations J Neuro-Oncol 93 395 400 10.1007/s11060-009-9796-5